IP Library Granted Patent US 10,695,435
Granted Patent B2
US 10,695,435 · App. 16/160,770 · Granted Jun 30, 2020

Composition comprising a polymeric reagent

Inventors: Michael D. Bentley (Huntsville, AL); Sean M. Culbertson (Gurley, AL); Samuel P. McManus (Huntsville, AL)
Assignee: Nektar Therapeutics
A61K47/60A61K38/26A61K38/28C07C235/68C07D207/46C07K14/575C08G61/02C08G65/338C08G65/3348C08G65/33396C08G65/48C08K5/13A61K31/765C08K2201/012
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,695,435
App. No.
16/160,770
Granted
Jun 30, 2020
Kind
B2
Abstract

The present invention provides conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates. The conjugates as well as the polymeric reagents used to form the conjugates include at least one of each the following: an aromatic moiety comprising an ionizable hydrogen atom, a spacer moiety, and a water-soluble polymer. Methods of making polymeric reagents and conjugates, as well as methods for administering conjugates and compositions, are also provided.

Claims (31)

1. A method for preparing a polymeric reagent, the method comprising:

(i) reducing the nitro group of 7-nitro-4-fluorenecarboxylic acid (I),

by reaction of (I) with a reducing agent to thereby form 4-carboxylic acid-7-amino fluorene (II),

(ii) converting (II) into 9-hydroxymethyl-4-carboxylic acid-7-(amidoglutaric acid)fluorene,

by either:

(ii-a) protecting the amino group of 4-carboxylic acid-7-amino fluorene (II) to thereby form 4-carboxylic acid-N-protected-7-amino fluorene (III),

(ii-b) reacting (III) with a formylating agent to thereby form 9-formyl-4-carboxylic acid-N-protected-7-amino fluorene (IV),

(ii-c) reducing the formyl group of (IV) to form 9-hydroxymethyl-4-carboxylic acid-N-protected-7-amino fluorene (V),

(ii-d) removing the N-protecting group from (V) to form 9-hydroxymethyl-4-carboxylic acid-7-amino fluorene (VI),

(ii-e) reacting (VI) with glutaric anhydride to form 9-hydroxymethyl-4-carboxylic acid-7-(amidoglutaric acid)fluorene (VII),

or

(ii-a′) reacting (II) with glutaric anhydride to form 4-carboxylic acid-7-(amidoglutaric acid)fluorene (IX),

(ii-b′) reacting (IX) with a formylating agent to form 9-formyl-4-carboxylic acid-7-(amidoglutaric acid)fluorene (X),

(ii-c′) reducing the formyl group of (X) to form 9-hydroxymethyl-4-carboxylic acid-7-(amidoglutaric acid)fluorene (VII),

(iii) reacting (VII) with methoxypoly(ethylene glycol)amine, mPEG-NH 2 , under conditions effective to form 9-hydroxymethyl-4-methoxypoly(ethylene glycol)carboxamide)-7-(methoxypoly(ethylene glycol)-glutaramide)fluorene (VIII),

and

(iv) converting the 9-hydroxymethyl group of (VIII) into an active carbonate ester, (XI).

2. The method of claim 1 , wherein step (ii) comprises steps (ii-a) through (ii-e).

3. The method of claim 1 , wherein step (ii) comprises steps (ii-a′) through (ii-c′).

4. The method of claim 1 , where in step (i), the nitro group of 7-nitro-4-fluorenecarboxylic acid is reduced by hydrogenation over a palladium/carbon catalyst.

5. The method of claim 2 , wherein the protecting group in 4-carboxylic acid-N-protected-7-amino fluorene (III) is a BOC (tert-butyloxycarbonyl) protecting group.

6. The method of claim 1 , wherein the formylating agent in step (ii-b) or in step (ii-b′) is ethyl formate.

7. The method of claim 1 , where in step (iii), mPEG-NH 2 is reacted with (VII) in the presence of a condensing agent and a base.

8. The method of claim 7 , wherein the condensing agent is 1,3-dicyclohexylcarbodiimide (DCC) or diisopropylcarbodiimide.

9. The method of claim 8 , wherein the condensing agent is 1,3-dicyclohexylcarbodiimide (DCC) and the base is N-hydroxybenzotriazole (HOBT).

10. The method of claim 1 , wherein the mPEG-NH 2 in step (iii) has a weight average molecular weight in a range selected from the group consisting of from about 120 daltons to about 6,000 daltons, from about 6,000 daltons to about 100,000 daltons, and from about 10,000 daltons to about 85,000 daltons.

11. The method of claim 1 , wherein the mPEG-NH 2 in step (iii) has a weight average molecular weight selected from the group consisting of about 10,000 daltons, about 20,000 daltons and about 30,000 daltons.

12. The method of claim 1 , wherein the active carbonate ester of step (viii) is an N-succinidmidyl carbonate ester or a benzotriazolyl carbonate ester.

13. The method of claim 12 , wherein step (viii) comprises reacting (VIII) with triphosgene and adding N-hydroxysuccinimide to thereby form the active carbonate ester (XI) having a structure,

14. The method of claim 1 , further comprising the steps of:

(ix) isolating and purifying the active carbonate ester in (XI).

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
SECURITY INTEREST Recorded Jan 10, 2019
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 047959/0737 →
Cited By (1)
US 12,713,590